The 340B Drug Pricing Program allows eligible healthcare organizations to purchase certain outpatient drugs at prices below the standard market price. The program was created to help covered entities stretch limited resources and support services for patients and communities that need them most.
Understanding 340B drug pricing is not just about getting a lower price. Organizations also need to understand eligibility, covered entities, program requirements, and the controls needed to stay compliant.
What Is the 340B Drug Pricing Program?
The 340B Drug Pricing Program is a federal program administered by the Health Resources and Services Administration (HRSA). It requires participating drug manufacturers to offer covered outpatient drugs to eligible healthcare organizations at or below a statutory ceiling price.
The program is available only to specific types of organizations and facilities that meet federal requirements. These organizations are known as 340B covered entities.
The goal is to help eligible providers use their resources more effectively while continuing to provide healthcare services to underserved populations.
Who Is Eligible for 340B?
Not every healthcare organization can participate in the program. 340B eligibility depends on the organization’s type and whether it meets the applicable requirements under federal law.
Examples of eligible categories include:
- Disproportionate Share Hospitals
- Children’s Hospitals
- Critical Access Hospitals
- Rural Referral Centers
- Sole Community Hospitals
- Federally Qualified Health Centers and certain health center programs
- Ryan White HIV/AIDS Program organizations
- Family planning clinics
- Sexually transmitted disease clinics
- Tribal and Urban Indian health organizations
- Certain specialized hospitals and treatment centers
HRSA’s current program data lists multiple covered-entity categories and their participation in the program.
Eligibility can also depend on specific statutory requirements. For example, a hospital category may need to meet additional criteria before it can participate. This is why organizations should verify their eligibility rather than assuming that a healthcare provider automatically qualifies.
How Do 340B Discounts Work?
The basic idea behind 340B discounts is straightforward. Eligible covered entities can purchase covered outpatient drugs at or below the applicable 340B ceiling price.
However, the actual price is not simply a fixed percentage discount that applies to every drug. The ceiling price is determined under the 340B statute and can vary based on the drug and pricing information.
Covered entities also need accurate purchasing and inventory processes. A discount only provides value when the organization can track which purchases are eligible and make sure the drugs are used within program rules.
For organizations managing large drug volumes, this can become a complex operational task.
What Are the Main 340B Compliance Requirements?
340B compliance requires more than maintaining an active registration. Covered entities must maintain accurate records and controls throughout their participation.
HRSA identifies several key requirements, including:
Keep Program Information Accurate
Covered entities need to keep their information in the 340B Office of Pharmacy Affairs Information System (OPAIS) accurate and current. This includes registering applicable outpatient facilities and contract pharmacies. Organizations must also complete annual recertification.
Prevent Diversion
340B drugs cannot be transferred or resold to people who are not eligible under the program. Organizations therefore need processes that connect drug purchases, patient eligibility, dispensing, and administration records.
Prevent Duplicate Discounts
One of the major 340B compliance requirements is preventing duplicate discounts.
A manufacturer generally should not have to provide both a 340B discount and a Medicaid drug rebate for the same drug. Covered entities need mechanisms to prevent this situation.
For Medicaid fee-for-service claims, organizations must also correctly manage their carve-in or carve-out approach and keep related information accurate in the Medicaid Exclusion File.
Maintain Audit-Ready Records
Covered entities should maintain records that demonstrate compliance with program requirements. HRSA notes that covered entities may be audited by manufacturers or the federal government. Noncompliance can result in liability for refunds of discounts obtained.
Why 340B Compliance Matters
The financial value of the program makes strong compliance controls especially important. HRSA reported more than $100 billion in 340B covered outpatient drug purchases in 2025, showing the scale of the program.
At that scale, even a small process problem can affect a large number of transactions.
Common areas of concern include:
- Incorrect patient eligibility
- Duplicate discounts
- Inaccurate contract pharmacy data
- Poor inventory tracking
- Outdated registration information
- Weak documentation
- Inconsistent internal processes
- Difficulty preparing for an audit
These are not issues that should be handled only when an audit is approaching. Regular monitoring is much easier than trying to reconstruct months or years of transactions later.
How Technology Can Support 340B Management
Technology can make 340B program management more organized by bringing data from different systems into a more consistent workflow.
A well-designed solution may help organizations:
- Validate purchasing and dispensing data
- Track eligible transactions
- Monitor contract pharmacy activity
- Identify potential duplicate discounts
- Maintain documentation
- Create audit trails
- Monitor exceptions and unusual transactions
- Support regular compliance reviews
- Generate reports for internal teams
The goal is not to replace compliance professionals. Technology gives those teams better visibility into the information they need to review.
Organizations looking to strengthen their healthcare operations can also explore specialized solutions and technology services through NorthArc Health.
How Can Organizations Stay Compliant?
A practical compliance approach starts with clear ownership. Someone should be responsible for monitoring the program and coordinating with pharmacy, finance, billing, IT, and clinical teams.
Organizations should also establish written policies for areas such as patient eligibility, purchasing, inventory, Medicaid billing, contract pharmacies, and record retention.
Regular reviews are equally important. Instead of waiting for an external 340B audit, internal teams can test samples, investigate exceptions, review system data, and document corrective actions.
Technology can support this process, but the underlying policies and staff responsibilities still matter.
Common Questions About 340B Drug Pricing
Is every healthcare provider eligible for 340B?
No. Participation is limited to specific categories of covered entities that meet applicable federal requirements.
Does 340B provide the same discount on every drug?
No. The 340B price is based on the statutory ceiling-price methodology, so the discount can vary by drug and pricing circumstances.
What happens if a covered entity violates 340B requirements?
A covered entity may face corrective actions and, depending on the circumstances, may be liable to manufacturers for refunds of discounts obtained.
Can technology guarantee 340B compliance?
No. Technology can support monitoring, data validation, documentation, and reporting, but compliance ultimately depends on accurate processes, trained staff, appropriate oversight, and adherence to applicable requirements.
Final Thoughts
340B drug pricing can provide meaningful value to eligible healthcare organizations, but participation comes with responsibilities. Eligibility must be maintained, discounts must be handled correctly, and organizations need reliable controls to prevent diversion and duplicate discounts.
The strongest approach combines clear policies, trained teams, accurate data, regular monitoring, and technology that makes compliance easier to manage. For organizations participating in the 340B Program, compliance should be an ongoing process rather than something addressed only when an audit is scheduled.
